Alfredo Molteni

2.3k total citations
37 papers, 480 citations indexed

About

Alfredo Molteni is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Alfredo Molteni has authored 37 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Genetics and 8 papers in Oncology. Recurrent topics in Alfredo Molteni's work include Acute Myeloid Leukemia Research (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Hematological disorders and diagnostics (5 papers). Alfredo Molteni is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Hematological disorders and diagnostics (5 papers). Alfredo Molteni collaborates with scholars based in Italy, United States and Australia. Alfredo Molteni's co-authors include Enrica Morra, Pierluigi Oreste, Giuliana Muti, Gianpaolo Carrafiello, A. Nosari, Marco Montillo, S. Grisanti, Armando Santoro, Salvatore Siena and Angelo Sala and has published in prestigious journals such as Blood, Electrochimica Acta and Diabetologia.

In The Last Decade

Alfredo Molteni

35 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alfredo Molteni Italy	13	191	129	126	104	85	37	480
Masatoshi Sakurai Japan	13	204 1.1×	93 0.7×	61 0.5×	114 1.1×	118 1.4×	69	497
Mohamad Sobh France	14	230 1.2×	102 0.8×	81 0.6×	132 1.3×	131 1.5×	61	476
Anne Troldborg Denmark	15	118 0.6×	48 0.4×	198 1.6×	65 0.6×	55 0.6×	64	788
Anna Maria Nosari Italy	13	280 1.5×	92 0.7×	93 0.7×	134 1.3×	203 2.4×	18	532
David Bloxham United Kingdom	11	179 0.9×	97 0.8×	39 0.3×	156 1.5×	48 0.6×	23	452
Sakhila Ghimire Germany	10	387 2.0×	109 0.8×	73 0.6×	71 0.7×	157 1.8×	20	692
Aarthi Shenoy United States	13	327 1.7×	109 0.8×	44 0.3×	104 1.0×	189 2.2×	41	649
Jacek M. Polski United States	13	225 1.2×	43 0.3×	74 0.6×	100 1.0×	59 0.7×	24	414
Aude Marie‐Cardine France	9	137 0.7×	56 0.4×	95 0.8×	44 0.4×	73 0.9×	24	414
Lysiane Molina France	14	544 2.8×	93 0.7×	88 0.7×	120 1.2×	159 1.9×	29	780

Countries citing papers authored by Alfredo Molteni

Since Specialization

Citations

This map shows the geographic impact of Alfredo Molteni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Molteni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Molteni more than expected).

Fields of papers citing papers by Alfredo Molteni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Molteni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Molteni. The network helps show where Alfredo Molteni may publish in the future.

Co-authorship network of co-authors of Alfredo Molteni

This figure shows the co-authorship network connecting the top 25 collaborators of Alfredo Molteni. A scholar is included among the top collaborators of Alfredo Molteni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfredo Molteni. Alfredo Molteni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, Giuseppe, Erika Borlenghi, Patrizia Zappasodi, et al.. (2024). Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda. Cancers. 16(2). 386–386. 6 indexed citations

Ungari, Marco, Simona Fisogni, Antonio Lavazza, et al.. (2021). Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma. Pathologica. 113(4). 285–293. 3 indexed citations

Passalacqua, Rodolfo, Margherita Ratti, Angelo Pan, et al.. (2021). 1646TiP Efficacy of SARS-CoV-2 vaccination in cancer patients during treatment: A prospective observational study (ANTICOV trial). Annals of Oncology. 32. S1161–S1161. 1 indexed citations

Schettini, Francesco, Navid Sobhani, Tiziana Triulzi, et al.. (2020). Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast Cancer Research and Treatment. 184(2). 421–431. 12 indexed citations

Molteni, Alfredo, Marta Riva, Michele Nichelatti, et al.. (2019). PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 11(1). e2019015–e2019015. 5 indexed citations

Girmenia, Corrado, Anna Candoni, Mario Delia, et al.. (2018). Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations. Blood Reviews. 34. 16–25. 14 indexed citations

Falconi, Giulia, Emiliano Fabiani, Alfonso Piciocchi, et al.. (2018). Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes. Leukemia. 33(3). 785–790. 24 indexed citations

Reda, Gianluigi, Marta Riva, Bruno Fattizzo, et al.. (2018). Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia. Seminars in Hematology. 55(4). 202–208. 5 indexed citations

Voso, Maria Teresa, Giuseppe Leone, Alfonso Piciocchi, et al.. (2017). Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study. Annals of Oncology. 28(7). 1547–1553. 39 indexed citations

10.

Molteni, Alfredo, Marta Riva, Laura Marbello, et al.. (2017). Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience. International Journal of Hematology. 105(6). 769–776. 7 indexed citations

11.

Riva, Marta, Alfredo Molteni, & Roberto Cairoli. (2016). A Proposal for a Novel Approach to Fitness in the Elderly Patients: The "NO-Chain" Algorithm. Blood. 128(22). 5943–5943. 1 indexed citations

12.

Molteni, Alfredo, Marta Riva, Michele Nichelatti, et al.. (2016). The Immunohistochemical Expression of p53 in Bone Marrow Biopsy Has Unfavorable Prognostic Impact in Higher Risk Myelodysplastic Syndromes If It Is at Least 10%. Blood. 128(22). 5546–5546.

13.

Efficace, Fabio, Valeria Santini, Giorgio La Nasa, et al.. (2014). Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy. BMJ Supportive & Palliative Care. 6(1). 80–88. 14 indexed citations

14.

Molteni, Alfredo, et al.. (2014). Danazol Treatment in Lower Risk MDS Patient with Severe Thrombocytopenia: A Monocentric Experience. Blood. 124(21). 5615–5615.

15.

Molteni, Alfredo, Marta Riva, Michele Nichelatti, et al.. (2013). Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the “International Working Group” criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience. International Journal of Hematology. 97(4). 472–479. 2 indexed citations

16.

Nosari, Anna Maria, Marta Riva, Laura Marbello, et al.. (2013). Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience. Leukemia & lymphoma. 55(8). 1844–1848. 12 indexed citations

17.

Balzarotti, Monica, S. Grisanti, Angelo Sala, et al.. (1999). Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.. PubMed. 26(2 Suppl 7). 66–71. 78 indexed citations

18.

Marder, Robert J., et al.. (1986). Phase II trial of tamoxifen in chronic lymphocytic leukemia.. PubMed. 70(11). 1343–4. 1 indexed citations

19.

Mari, C.M., Alfredo Molteni, & S. Pizzini. (1979). Gas phase electrocatalytic oxidation of SO2 by solid state electrochemical technique. Electrochimica Acta. 24(7). 745–750. 6 indexed citations

20.

Molteni, Alfredo, et al.. (1975). Resistance of W/Fu Rats to Adrenal Regeneration Hypertension. Experimental Biology and Medicine. 150(1). 80–84. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact